CoChat

Determination of factors affecting medication adherence in type 2 diabetes mellitus patients using a nationwide claim-based database in Japan

Horii, Takeshi, Momo, Kenji, Yasu, Takeo, Kabeya, Yusuke, Atsuda, Koichiro · 2019 · PLOS ONE
Cited by 55

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0223431

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 32

  1. L Osterberg, 2005, Adherence to medication, N Engl J Med, 353, 487, 10.1056/NEJMra050100 · DOI · Paper page
  2. J Cramer, 2003, VA Naltrexone Study Group 425. Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes, Value Health, 6, 566, 10.1046/j.1524-4733.2003.65269.x · DOI · Paper page
  3. B Waeber, 1999, Compliance with aspirin or placebo in the Hypertension Optimal Treatment (HOT) study, J Hypertens, 17, 1041, 10.1097/00004872-199917070-00022 · DOI
  4. AJ Claxton, 2001, A systematic review of the associations between dose regimens and medication compliance, Clin Ther, 23, 1296, 10.1016/S0149-2918(01)80109-0 · DOI · Paper page
  5. CJ Bailey, 2011, Patient adherence to medication requirements for therapy of type 2 diabetes, Int J Clin Pract, 65, 314, 10.1111/j.1742-1241.2010.02544.x · DOI · Paper page
  6. I Krass, 2015, Adherence to diabetes medication: a systematic review, Diabet Med, 32, 725, 10.1111/dme.12651 · DOI · Paper page
  7. H Fukuda, 2017, Impact of nonadherence on complication risks and healthcare costs in patients newly-diagnosed with diabetes, Diabetes Res Clin Pract, 123, 55, 10.1016/j.diabres.2016.11.007 · DOI
  8. S Sapkota, 2015, A systematic review of interventions addressing adherence to anti-diabetic medications in patients with type 2 diabetes–components of interventions, PLoS One, 10, e0118296, 10.1371/journal.pone.0118296 · DOI · Paper page
  9. S Kimura, 2010, Development of a database of health insurance claims: standardization of disease classifications and anonymous record linkage, J Epidemiol, 20, 413, 10.2188/jea.JE20090066 · DOI · Paper page
  10. S Nakaoka, 2011, Echocardiography for the detection of valvulopathy associated with the use of ergot-derived dopamine agonists in patients with Parkinson's disease, Intern Med, 50, 687, 10.2169/internalmedicine.50.4344 · DOI
  11. TB Gibson, 2010, Cost sharing, adherence, and health outcomes in patients with diabetes, Am J Manag Care, 16, 589
  12. DT Juarez, 2013, Factors affecting sustained medication adherence and its impact on health care utilization in patients with diabetes, J Pharm Health Serv Res, 4, 89, 10.1111/jphs.12016 · DOI · Paper page
  13. NK Choudhry, 2009, Measuring concurrent adherence to multiple related medications, Am J Manag Care, 15, 457
  14. N Masnoon, 2017, What is polypharmacy? A systematic review of definitions, BMC Geriatr, 17, 230, 10.1186/s12877-017-0621-2 · DOI · Paper page
  15. K Tunceli, 2015, Factors associated with adherence to oral antihyperglycemic monotherapy in patients with type 2 diabetes, Patient Prefer Adherence, 9, 191
  16. E Raum, 2012, Medication non-adherence and poor glycaemic control in patients with type 2 diabetes mellitus, Diabetes Res Clin Pract, 97, 377, 10.1016/j.diabres.2012.05.026 · DOI
  17. A Patel, 2008, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes, N Engl J Med, 358, 2560, 10.1056/NEJMoa0802987 · DOI · Paper page
  18. RM Jamous, 2011, Adherence and satisfaction with oral hypoglycemic medications: a pilot study in Palestine., Int J Clin Pharm, 33, 942, 10.1007/s11096-011-9561-7 · DOI
  19. J Kreyenbuhl, 2010, Does adherence to medications for type 2 diabetes differ between individuals with vs without schizophrenia?, Schizophr Bull., 36, 428, 10.1093/schbul/sbn106 · DOI · Paper page
  20. NS Ahmad, 2013, Medication adherence in patients with type 2 diabetes mellitus treated at primary health clinics in Malaysia., Patient Prefer Adherence, 7, 525
  21. SM Curkendall, 2013, Predictors of medication adherence in patients with type 2 diabetes mellitus, Curr Med Res Opin, 29, 1275, 10.1185/03007995.2013.821056 · DOI · Paper page
  22. PT Donnan, 2002, Adherence to prescribed oral hypoglycaemic medication in a population of patients with type 2 diabetes: a retrospective cohort study, Diabet Med, 19, 279, 10.1046/j.1464-5491.2002.00689.x · DOI · Paper page
  23. RP Hertz, 2005, Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer sponsored health insurance, Clin Ther, 27, 1064, 10.1016/j.clinthera.2005.07.009 · DOI · Paper page
  24. Y Hayashino, 2011, Depressive symptoms, not completing a depression screening questionnaire, and risk of poor compliance with regular primary care visits in patients with type 2 diabetes: the Japan Diabetes Outcome Intervention Trial 2 (J-DOIT2) study group, Exp Clin Endocrinol Diabetes, 119, 276, 10.1055/s-0030-1265213 · DOI
  25. K Kurtyka, 2016, Adherence to dipeptidyl peptidase-4 inhibitor therapy among type 2 diabetes patients with employer-sponsored health insurance in Japan., J Diabetes Investig, 7, 737, 10.1111/jdi.12474 · DOI
  26. T Horii, 2019, Polypharmacy and oral antidiabetic treatment for type 2 diabetes characterised by drug class and patient characteristics: A Japanese database analysis, Sci Rep, 9, 12992, 10.1038/s41598-019-49424-2 · DOI
  27. K Fujihara, 2017, Comparison of baseline characteristics and clinical course in Japanese patients with type 2 diabetes among whom different types of oral hypoglycemic agents were chosen by diabetes specialists as initial monotherapy (JDDM 42)., Medicine, 96, e6122, 10.1097/MD.0000000000006122 · DOI
  28. Y Hayashino, 2016, A cluster randomized trial on the effect of a multifaceted intervention improved the technical quality of diabetes care by primary care physicians: The Japan Diabetes Outcome Intervention Trial-2 (J-DOIT2)., Diabet Med, 33, 599, 10.1111/dme.12949 · DOI
  29. AS Adams, 2008, Medication adherence and racial differences in A1C control, Diabetes Care, 31, 916, 10.2337/dc07-1924 · DOI · Paper page
  30. CM Trinacty, 2009, Racial differences in long-term adherence to oral antidiabetic drug therapy: a longitudinal cohort study, BMC Health Serv Res, 9, 24, 10.1186/1472-6963-9-24 · DOI · Paper page
  31. M Nagasawa, 1990, Meta-analysis of correlates of diabetes patients' compliance with prescribed medications, Diabetes Educ, 16, 192, 10.1177/014572179001600309 · DOI · Paper page
  32. J Lawton, 2008, Patients' perceptions and experiences of taking oral glucose-lowering agents: a longitudinal qualitative study, Diabet Med, 25, 491, 10.1111/j.1464-5491.2008.02400.x · DOI

Cited by

See all 55

Metadata

Authors
Horii, T., Momo, K., Yasu, T., Kabeya, Y., & Atsuda, K.
Venue
PLOS ONE
Published
2019-10-08
Volume
14
Issue
10
Pages
e0223431
ISSN
1932-6203
Cited by
55
References
5
Language
en
Funders
the Japan Diabetes Society Medical Staff Training and Research Fund. (2017-17)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Determination of factors affecting medication adherence in type 2 diabetes mellitus patients using a nationwide claim-based database in Japan. https://app.cochat.ai/papers/10.1371/journal.pone.0223431
The paper
Horii, T., Momo, K., Yasu, T., Kabeya, Y., & Atsuda, K. (2019). Determination of factors affecting medication adherence in type 2 diabetes mellitus patients using a nationwide claim-based database in Japan. PLOS ONE. https://doi.org/10.1371/journal.pone.0223431

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.